Alternatives to IDBS

Cloud-based scientific R&D software for life sciences and chemistry.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

Biostax provides a cloud-based platform for life sciences research, enabling data integration and analysis.

AI operating system for R&D teams in formulation industries.

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Developing engineered biologics to harness the immune system for disease treatment.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

AI-powered platform for personalized cell therapy development and manufacturing.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Biotechnology company developing novel immunotherapies for cancer.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

Gene therapy company developing treatments for rare inherited diseases.

Gene therapy company developing transformative treatments for severe genetic diseases.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Develops and manufactures biologics for therapeutic applications.

Developing novel therapeutics for challenging diseases using advanced biological insights.

Biotech company focused on developing therapies to extend human healthspan and lifespan.

Developing advanced cell culture media and bioprocessing solutions for cell and gene therapy.

Global marketplace connecting researchers with human biospecimens for life science research.

Metly empowers pharma companies to accelerate product launches through intelligent opportunity detection and partner matching.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.

Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.

VISEN Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies for inflammatory and fibrotic diseases.

Develops novel therapeutic antibodies for oncology and autoimmune diseases.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

AI-powered platform for antibody discovery and development to create new medicines.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Biopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.

Lutris Pharma is a biotechnology company focused on developing novel therapies for rare genetic diseases.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

Biopharmaceutical company focused on rare genetic diseases of obesity.

A global, research-driven biopharmaceutical group focused on reproductive medicine, maternal health, and other specialized therapeutic areas.

Developing novel therapies for neurological disorders.

Develops advanced gene editing and cell therapy solutions for rare genetic diseases.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Canadian company operating in the legal psilocybin industry, focusing on cultivation, production, and distribution of psilocybin products.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.